Atlas Trials

Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer

Clinical trial NCT02433639 · COMPLETED

Trial details

NCT number
NCT02433639
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Tract Cancer
Start date
2015-04-01
Primary completion
2017-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.